| Disease-specific induced pluripotent stem cells IH Park, N Arora, H Huo, N Maherali, T Ahfeldt, A Shimamura, MW Lensch, ... cell 134 (5), 877-886, 2008 | 2785 | 2008 |
| Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution N Maherali, R Sridharan, W Xie, J Utikal, S Eminli, K Arnold, M Stadtfeld, ... Cell stem cell 1 (1), 55-70, 2007 | 2245 | 2007 |
| Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse M Stadtfeld, N Maherali, DT Breault, K Hochedlinger Cell stem cell 2 (3), 230-240, 2008 | 1063 | 2008 |
| Immortalization eliminates a roadblock during cellular reprogramming into iPS cells J Utikal, JM Polo, M Stadtfeld, N Maherali, W Kulalert, RM Walsh, A Khalil, ... Nature 460 (7259), 1145-1148, 2009 | 1061 | 2009 |
| A high-efficiency system for the generation and study of human induced pluripotent stem cells N Maherali, T Ahfeldt, A Rigamonti, J Utikal, C Cowan, K Hochedlinger Cell stem cell 3 (3), 340-345, 2008 | 734 | 2008 |
| Guidelines and techniques for the generation of induced pluripotent stem cells N Maherali, K Hochedlinger Cell stem cell 3 (6), 595-605, 2008 | 637 | 2008 |
| Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming J Deng, R Shoemaker, B Xie, A Gore, EM LeProust, ... Nature biotechnology 27 (4), 353-360, 2009 | 636 | 2009 |
| Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination S Wang, J Bates, X Li, S Schanz, D Chandler-Militello, C Levine, ... Cell stem cell 12 (2), 252-264, 2013 | 627 | 2013 |
| Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells S Eminli, A Foudi, M Stadtfeld, N Maherali, T Ahfeldt, G Mostoslavsky, ... Nature genetics 41 (9), 968-976, 2009 | 537 | 2009 |
| Tgfβ signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc N Maherali, K Hochedlinger Current biology 19 (20), 1718-1723, 2009 | 436 | 2009 |
| Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells J Utikal, N Maherali, W Kulalert, K Hochedlinger Journal of cell science 122 (19), 3502-3510, 2009 | 418 | 2009 |
| A reprogrammable mouse strain from gene-targeted embryonic stem cells M Stadtfeld, N Maherali, M Borkent, K Hochedlinger Nature methods 7 (1), 53-55, 2010 | 249 | 2010 |
| Fibroblast-derived induced pluripotent stem cells show no common retroviral vector insertions F Varas, M Stadtfeld, L de Andres-Aguayo, N Maherali, A Di Tullio, ... Stem cells 27 (2), 300-306, 2009 | 86 | 2009 |
| A serial shRNA screen for roadblocks to reprogramming identifies the protein modifier SUMO2 M Borkent, BD Bennett, B Lackford, O Bar-Nur, J Brumbaugh, L Wang, ... Stem cell reports 6 (5), 704-716, 2016 | 63 | 2016 |
| Induced pluripotency of mouse and human somatic cells N Maherali, K Hochedlinger Cold Spring Harbor symposia on quantitative biology 73, 157-162, 2008 | 39 | 2008 |
| Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma J Repass, N Maherali, K Owen, Reproducibility Project: Cancer Biology Elife 5, 299-306, 2016 | 30 | 2016 |
| Methods of generating pluripotent cells from somatic cells K Hochedlinger, N Maherali US Patent App. 12/602,184, 2010 | 25 | 2010 |
| Inducible lentiviral vectors for reprogramming somatic cells K Hochedlinger, N Maherali US Patent App. 12/364,147, 2010 | 23 | 2010 |
| Reproducibility Project: Cancer Biology; Reproducibility Project Cancer Biology: Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma J Repass, N Maherali, K Owen Elife 5, e10012, 2016 | 14 | 2016 |
| Registered report: tumour vascularization via endothelial differentiation of glioblastoma stem-like cells D Chroscinski, D Sampey, N Maherali, ... Elife 4, 824-828, 2015 | 11 | 2015 |
